|
|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2026
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/34732
| Title: | CLINICAL EVOLUTION OF SARS-COV-2 INFECTION IN A PRETERM NEWBORN |
| Authors: | Rotari, Olga Selevestru, Rodica Călcîi, Cornelia Petrovici, Vergii |
| Keywords: | SARS-CoV-2;prematurity |
| Issue Date: | 2026 |
| Publisher: | Centrul Editorial-Poligrafic Medicina |
| Citation: | Rotari, Olga; Selevestru, Rodica; Călcîi, Cornelia; Petrovici, Vergii. CLINICAL EVOLUTION OF SARS-COV-2 INFECTION IN A PRETERM NEWBORN. In: MedEspera 2026, p. 918. ISBN 978-9975-82-486-6. |
| Abstract: | Introduction. SARS-CoV-2 infection during pregnancy raises concerns about effects on the fetus and newborn, especially preterm infants, who have an increased risk of complications. Preterm newborns are vulnerable due to immature respiratory, immune, and metabolic systems, predisposing them to severe outcomes. Management requires careful monitoring and multidisciplinary treatment. Case presentation. A female infant was born from the first pregnancy at 30 weeks gestation, birth weight 1630 g, length 43 cm, Apgar score 5/6/6. The mother had chorioamnionitis, intrapartum fever, and tested positive for SARS-CoV-2; delivery was by emergency cesarean section. Initial resuscitation (Step A+B) was performed, and the newborn was transferred to the neonatal ICU with respiratory distress syndrome, placed on nasal CPAP. Chest X-ray revealed congenital pneumonia. Antibiotic therapy with Ampicillin 100 mg/kg/12 h and Amikacin 15 mg/kg/36 h was started, along with Hydrocortisone, Caffeine, and Erythropoietin. Initial evolution was stable. On day 9, clinical deterioration occurred, and SARS-CoV-2 PCR was positive. Examination revealed pale-pink marbled skin, perioral cyanosis, diminished reflexes, and respiratory failure signs. Labs showed leukocytosis with neutrophilia; blood gas analysis revealed compensated respiratory acidosis. Chest X-ray confirmed bilateral bronchopneumonia. Treatment was adjusted to Cefepime 30 mg/kg/12 h, later combined with Azithromycin 10 mg/kg/24 h, antiviral therapy with Viferon 150,000 IU/12 h, antifungals, corticosteroids, and adapted parenteral and enteral nutrition. PCR remained positive at 16 days, requiring ongoing therapy and close monitoring. Discussions. Managing preterm newborns with SARS-CoV-2 infection and respiratory complications is challenging. Prematurity, maternal infection, and pulmonary pathology increase the risk of severe evolution and necessitate complex interventions. Conclusions. Preterm infants with low birth weight may remain clinically stable after COVID-19 exposure if early supportive care, continuous monitoring, and strict infection control are applied. Vigilance for subtle respiratory or systemic signs is essential in neonatal units. |
| metadata.dc.relation.ispartof: | MedEspera 2026. The 11th International Medical Congress for Students and Young Doctors, 6-8 May 2026 |
| URI: | https://medespera.md/documents/abstract-book-4.pdf https://repository.usmf.md/handle/20.500.12710/34732 |
| ISBN: | 978-9975-82-486-6 |
| Appears in Collections: | MedEspera 2026
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|